Physician profile
Garrett A Wirth
NPI 1871605386
$361,704.58
in general payments reported to CMS, 2019-2025
23 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $19K · 2021: $1,699 · 2022: $45K · 2023: $98K · 2024: $39K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $66K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $20K · Education: $7,040 · Food and Beverage: $5,812 · Consulting Fee: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $66,320.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,140.00 |
| Travel and Lodging | $19,671.37 |
| Education | $7,040.00 |
| Food and Beverage | $5,812.13 |
| Consulting Fee | $960.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $288,560.33 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice, 3m Cavilon |
| Solventum Corporation | $50,111.33 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Musculoskeletal Transplant Foundation INC. | $17,217.94 | 2019-2025 | |
| Mentor Worldwide LLC | $1,664.66 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant, Mentor Cpx 2 Breast Tissue Expander |
| Sientra, INC. | $998.16 | 2019-2022 | |
| Abbvie INC. | $707.18 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $411.64 | 2019-2022 | |
| Organogenesis INC. | $298.42 | 2024 | Puraply Wound Matrix |
| Davol INC. | $227.37 | 2022 | |
| Smith+Nephew, INC. | $170.15 | 2021-2022 | |
| Polynovo North America LLC | $164.56 | 2024 | Novosorb Btm |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Revance Therapeutics, INC. | $139.81 | 2024 | Daxxify |
| Lifenet Health | $132.38 | 2024 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $127.29 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $123.17 | 2019 | |
| Innovation Technologies INC | $118.89 | 2020 | |
| Tela Bio, INC. | $103.00 | 2024 | Ovitex 2s |
| My01 INC. | $76.91 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Solta Medical, A Division of Bausch Health US, LLC | $69.13 | 2023 | |
| Acelrx Pharmaceuticals, INC. | $67.50 | 2021 | |
| Galderma Laboratories, L.P. | $50.75 | 2020-2024 | |
| Pacira Pharmaceuticals Incorporated | $19.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Wirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.